In our cohort, 14% of recipients received organs from donors with BSI but only five CRE DDIs were observed. Receiving organs from donors with unrecognized MDR BSI may adversely affect recipient outcomes; further studies are needed to determine whether newer antimicrobial agents can mitigate this risk.
Cona et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: